⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2828422 | 0.97 | — | — | |
| SCHEMBL2829629 | 0.94 | — | — | |
| SCHEMBL5249613 | 0.69 | — | — | |
| SCHEMBL4063215 | 0.67 | — | — | |
| SCHEMBL6057095 | 0.67 | — | — | |
| SCHEMBL8700399 | 0.67 | — | — | |
| SCHEMBL13057106 | 0.65 | — | — | |
| SCHEMBL28848005 | 0.64 | — | — | |
| SCHEMBL11840925 | 0.63 | — | — | |
| SCHEMBL3961037 | 0.63 | ADH1A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111511895-B | Scaffold material for stem cell culture and stem cell culture method using same | 积水化学工业株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-111511896-B | Scaffold material for stem cell culture and stem cell culture method using same | 积水化学工业株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-115926568-B | Resin film formed of cell culture scaffold material, cell culture carrier, and cell culture container | 积水化学工业株式会社 | 2025-05-09 | — | — | CN | disclosed |
| US-12258349-B2 | Anti-viral drug | DORING INTERNATIONAL GMBH (CH) | 2025-03-25 | — | — | US | disclosed |
| CN-116904079-A | Resin film formed of cell culture scaffold material, cell culture carrier, and cell culture container | 积水化学工业株式会社 | 2023-10-20 | — | — | CN | disclosed |
| CN-113166580-B | Resin film formed of cell culture scaffold material, cell culture carrier, and cell culture container | 积水化学工业株式会社 | 2023-07-07 | — | — | CN | disclosed |
| US-20220298164-A1 | ANTI-VIRAL DRUG | DORING INTERNATIONAL GMBH (CN) | 2022-09-22 | — | — | US | disclosed |
| US-11370797-B2 | Anti-viral drug | DORING INTERNATIONAL GMBH (CH) | 2022-06-28 | — | — | US | disclosed |
| WO-2010151160-A1 | O-SUBSTITUTED 3-N-HETEROARYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL - PORTELA & CA., S.A. (PT) | 2010-12-29 | — | — | WO | disclosed |
| EP-2238131-A1 | 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL - Portela & Ca., S.A. (PT) | 2010-10-13 | — | — | EP | disclosed |
| WO-2010074587-A2 | 5-O-SUBSTITUTED 3-N-ARYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL - PORTELA & CA., S.A. (PT) | 2010-07-01 | — | — | WO | disclosed |
| WO-2009084970-A1 | 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL-PORTELA & COMPANHIA, S.A. (PT) | 2009-07-09 | — | — | WO | disclosed |
| US-20040044226-A1 | Estrogen receptor modulators | DININNO FRANK P (US) | 2004-03-04 | — | — | US | disclosed |
| EP-1333827-A2 | ESTROGEN RECEPTOR MODULATORS | Merck & Co., Inc. (US) | 2003-08-13 | — | — | EP | disclosed |
| EP-1328522-A2 | ESTROGEN RECEPTOR MODULATORS | Merck & Co., Inc. (US) | 2003-07-23 | — | — | EP | disclosed |
| WO-2002032373-A2 | ESTROGEN RECEPTOR MODULATORS | MERCK & CO., INC. (US) | 2002-04-25 | — | — | WO | disclosed |
| WO-2002032377-A2 | ESTROGEN RECEPTOR MODULATORS | MERCK & CO., INC. (US) | 2002-04-25 | — | — | WO | disclosed |